DUBLIN, Aug. 1, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) today announced positive four-week results from a […] KENILWORTH, N.J.–(BUSINESS WIRE)–July 24, 2018 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced […] SOUTH SAN FRANCISCO, Calif., July 18, 2018 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on […] Data from 3.7 million hospital admissions for sepsis from 1,000 US hospitals, presented at this year’s European Congress on Obesity […] Britain’s government says it has modified a controversial data-sharing agreement that allowed officials to track down people who might have […] Big data isn’t just an empty buzzword getting tossed around in the realms of business, health and science. For nursing […]data
Theravance Biopharma Reports Positive Top-Line Four-Week Data from Phase 2 Trial of TD-9855 for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine
Catalyst Biosciences Announces Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
Nationwide data shows that overweight and obese patients are less likely to die from sepsis in hospital than patient
UK makes it harder for officials to get patient data
Nursing researcher’s storytelling tool brings together small stories and big data
Copyright © 2025